To receive regular updates on research, policy change, lifestyle and fundraising, why not sign up for our monthly Newsletter here.
To receive regular updates on research, policy change, lifestyle and fundraising, why not sign up for our monthly Newsletter here.
In the last weeks of 2022, Teplizumab, the world’s first type 1 diabetes disease-modifying drug, has been approved for use by the USA’s Food and Drug Administration (FDA). It is an immunotherapy drug... View Article
Read MoreA concerned parent of a child with diabetes and a member of Diabetes Ireland contacted us recently to highlight their, and other parents’, concerns regarding the information on the Aer... View Article
Read MoreDiabetes Ireland and Diabetes Ireland Research Alliance, together with Irish Research Council have agreed to co-fund a two-year research project aimed at estimating the economic cost of diabetes care in... View Article
Read MoreIn the August 2022 edition of our magazine, Deborah speaks with Jean Langford about her Type 1 diabetes journey after her diagnosis at the young age of 11. Now at... View Article
Read MoreThis is the theme for this year’s World Diabetes Day, a day that the diabetes community come together to raise awareness of the condition. Diabetes is a serious health... View Article
Read More